QUOTED. 18 July 2019. Suzanne Schwartz.
Executive Summary
The US FDA's Suzanne Schwartz says a new law might be the antidote to companies that willingly hide cybersecurity vulnerabilities to avoid concerning their customers. Check out her comments here.
"We certainly want to see much broader adoption of coordinated vulnerability disclosure across the entire ecosystem. We may be looking to require coordinated vulnerability disclosure through legislation in order to level the playing field." – Suzanne Schwartz, deputy director, the Center for Devices and Radiological Health's Office of Strategic Partnerships and Technology Innovation, US FDA
Click here for a free trial of Medtech Insight